Dr. Leroy Nickles, M.D

NPI: 1710070412
Total Payments
$64,172
2024 Payments
$300.00
Companies
8
Transactions
94
Medicare Patients
1,725
Medicare Billing
$235,767

Payment Breakdown by Category

Other$47,690 (74.3%)
Travel$13,738 (21.4%)
Food & Beverage$2,744 (4.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $47,690 24 74.3%
Travel and Lodging $13,738 29 21.4%
Food and Beverage $2,744 41 4.3%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $40,785 41 $0 (2020)
AstraZeneca Pharmaceuticals LP $12,398 22 $0 (2024)
Alexion Pharmaceuticals, Inc. $10,877 24 $0 (2022)
Janssen Pharmaceuticals, Inc $29.38 2 $0 (2020)
PORTOLA PHARMACEUTICALS, LLC $29.09 2 $0 (2020)
E.R. Squibb & Sons, L.L.C. $23.21 1 $0 (2020)
ABBVIE INC. $18.81 1 $0 (2023)
PFIZER INC. $11.15 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $300.00 1 AstraZeneca Pharmaceuticals LP ($300.00)
2023 $4,433 14 AstraZeneca Pharmaceuticals LP ($4,414)
2022 $8,682 11 AstraZeneca Pharmaceuticals LP ($7,684)
2021 $9,880 21 Alexion Pharmaceuticals, Inc. ($9,880)
2020 $106.74 6 Genentech USA, Inc. ($37.58)
2019 $40,757 40 Genentech USA, Inc. ($40,733)
2017 $14.62 1 Genentech USA, Inc. ($14.62)

All Payment Transactions

94 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
06/13/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $300.00 General
Category: Rare Disease
11/16/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $300.00 General
Category: Rare Disease
10/12/2023 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $18.81 General
Category: ANTI-INFECTIVE
06/01/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,750.00 General
Category: Rare Disease
05/05/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $86.33 General
Category: Rare Disease
05/05/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $57.60 General
Category: Rare Disease
05/05/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $18.00 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $407.36 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $347.58 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $209.00 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $129.40 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $28.80 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $16.20 General
Category: Rare Disease
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $14.40 General
Category: Rare Disease
03/27/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $49.37 General
Category: Rare Disease
11/01/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,700.00 General
Category: Rare Disease
10/25/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Rare Disease
10/25/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $117.50 General
Category: Rare Disease
10/02/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Food and Beverage In-kind items and services $32.86 General
Category: Rare Disease
09/13/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,700.00 General
Category: Rare Disease
09/08/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Travel and Lodging In-kind items and services $1,016.82 General
Category: Rare Disease
09/08/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Rare Disease
05/13/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $915.00 General
Category: Rare Disease
05/10/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
Category: Rare Disease
02/20/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
Category: Rare Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 454 472 $566,589 $57,610
2022 5 439 446 $500,386 $57,271
2021 4 414 422 $517,296 $61,113
2020 4 418 422 $522,199 $59,773
Total Patients
1,725
Total Services
1,762
Medicare Billing
$235,767
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 242 256 $363,015 $37,151 10.2%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 150 154 $147,506 $15,434 10.5%
99291 Critical care, first 30-74 minutes Facility 2023 22 22 $39,919 $3,607 9.0%
99283 Emergency department visit with low level of medical decision making Facility 2023 25 25 $14,799 $1,314 8.9%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 15 15 $1,350 $103.80 7.7%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 278 280 $388,464 $44,887 11.6%
99284 Emergency department visit for problem of high severity Facility 2022 56 57 $53,053 $6,094 11.5%
99291 Critical care, first 30-74 minutes Facility 2022 17 19 $34,138 $3,785 11.1%
99283 Emergency department visit for problem of moderate severity Facility 2022 34 34 $19,691 $2,106 10.7%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 54 56 $5,040 $399.14 7.9%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 296 304 $409,139 $48,310 11.8%
99284 Emergency department visit, problem of high severity Facility 2021 65 65 $59,120 $7,016 11.9%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 18 18 $30,658 $3,597 11.7%
99283 Emergency department visit, moderately severe problem Facility 2021 35 35 $18,379 $2,191 11.9%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 292 296 $393,818 $45,850 11.6%
99284 Emergency department visit, problem of high severity Facility 2020 73 73 $68,175 $7,290 10.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 26 26 $43,661 $5,201 11.9%
99283 Emergency department visit, moderately severe problem Facility 2020 27 27 $16,545 $1,431 8.7%

About Dr. Leroy Nickles, M.D

Dr. Leroy Nickles, M.D is a Emergency Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710070412.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leroy Nickles, M.D has received a total of $64,172 in payments from pharmaceutical and medical device companies, with $300.00 received in 2024. These payments were reported across 94 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($47,690).

As a Medicare-enrolled provider, Nickles has provided services to 1,725 Medicare beneficiaries, totaling 1,762 services with total Medicare billing of $235,767. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Emergency Medicine, Emergency Medicine
  • Location New York, NY
  • Active Since 10/02/2006
  • Last Updated 03/21/2024
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1710070412

Products in Payments

  • Activase (Biological) $20,815
  • ANDEXXA (Biological) $13,425
  • Andexxa (Drug) $9,880
  • ELIQUIS (Drug) $34.36
  • XARELTO (Drug) $29.38
  • DALVANCE (Drug) $18.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in New York